Search

Your search keyword '"Callanan M"' showing total 302 results

Search Constraints

Start Over You searched for: Author "Callanan M" Remove constraint Author: "Callanan M"
302 results on '"Callanan M"'

Search Results

1. Long‐term analysis of the RiBVD phase II trial reveals the unfavorable impact of TP53 mutations and hypoalbuminemia in elderly mantle cell lymphoma patients. For the LYSA group.

4. P451: PRMT2: AN ANTI-INFLAMMATORY EPIGENETIC FACTOR INVOLVED IN ACUTE MYELOID LEUKEMIA AGGRESSIVENESS

8. HIGH‐RISK MANTLE CELL LYMPHOMA IN THE LYMA TRIAL: A LYSA STUDY

10. Recurrent genomic aberrations combined with deletions of various tumour suppressor genes may deregulate the G1/S transition in CD4+CD56+ haematodermic neoplasms and contribute to the aggressiveness of the disease

11. The MLL recombinome of acute leukemias in 2013

22. Antioxidant activity and characterization of whey protein-based beverages: Effect of shelf life and gastrointestinal transit on bioactivity

23. Construction of a rhizosphere pseudomonad with potential to degrade polychlorinated biphenyls and detection of bph gene expression in the rhizosphere

26. Erratum: Recurrent genomic aberrations combined with deletions of various tumour suppressor genes may deregulate the G1/S transition in CD4+CD56+ haematodermic neoplasms and contribute to the aggressiveness of the disease

28. FIRST LINE TREATMENT BY THE RIBVD REGIMEN ELICITS HIGH CLINICAL AND MOLECULAR RESPONSE RATES AND PROLONGED SURVIVAL IN ELDERLY MCL PATIENTS; FINAL RESULTS OF a LYSA GROUP TRIAL

31. Reforming local government: Past, present and future

34. An Opportunity to Improve Upon the U.S. Military-Media Relationship: Institutionalizing Embedded Media Into the Mainstream Military

36. Telomeres and chromosomal instability in chronic lymphocytic leukemia

50. Genetics and epigenetics of 1q rearrangements in hematological malignancies.

Catalog

Books, media, physical & digital resources